Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats

2012 ◽  
Vol 62 (5-6) ◽  
pp. 2096-2105 ◽  
Author(s):  
Ashley M. Melichercik ◽  
Kevin S. Elliott ◽  
Cristina Bianchi ◽  
Sarah M. Ernst ◽  
Boyer D. Winters
2007 ◽  
Vol 102 (6) ◽  
pp. 1842-1852 ◽  
Author(s):  
Javier Egea ◽  
Angelo O. Rosa ◽  
Antonio Cuadrado ◽  
Antonio G. García ◽  
Manuela G. López

Hippocampus ◽  
2011 ◽  
Vol 22 (6) ◽  
pp. 1392-1404 ◽  
Author(s):  
Vicky L. Navaroli ◽  
Yanjun Zhao ◽  
Pawel Boguszewski ◽  
Thomas H. Brown

2013 ◽  
Vol 170 (6) ◽  
pp. 1221-1232 ◽  
Author(s):  
M J Nguyen ◽  
S Angkawaijawa ◽  
H Hashitani ◽  
R J Lang

2021 ◽  
Author(s):  
Anthony Auerbach

Agonists are classified by the strength at which they bind to their target sites (affinity) and their ability to activate receptors once bound to those sites (efficacy). Efficiency is a third fundamental agonist property that is a measure of the correlation between affinity and efficacy. Efficiency is the percent of agonist binding energy that is converted into energy for receptor activation ('gating'). In the muscle nicotinic acetylcholine receptor, agonists belong to families having discrete efficiencies of 54%, 51%, 42% or 35%. Efficiency depends on the size and composition of both the agonist and binding site, and can be estimated from, and used to interpret, concentration-response curves. A correlation between affinity and efficacy indicates that the agonist's energy changes that take place within binding and gating processes are linked. Efficiency suggests that receptors turn on and off by progressing through a sequence of energy-linked domain rearrangements, as in a zipper.


2000 ◽  
Vol 20 (1) ◽  
pp. 66-75 ◽  
Author(s):  
Manickavasagom Alkondon ◽  
Edna F. R. Pereira ◽  
Howard M. Eisenberg ◽  
Edson X. Albuquerque

Nutrients ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 2469 ◽  
Author(s):  
Tatsuhiro Ayabe ◽  
Yasuhisa Ano ◽  
Rena Ohya ◽  
Shiho Kitaoka ◽  
Tomoyuki Furuyashiki

Scope: Peptides containing tryptophan–tyrosine sequences, including the lacto-tetrapeptide glycine–threonine–tryptophan–tyrosine (GTWY) and β-lactolin, from β-lactoglobulin in whey enzymatic digestion, enhance hippocampus-dependent memory functions, which are blocked by the systemic administration of dopamine D1-like antagonist. In this study, we investigated the role of the hippocampal dopaminergic system in the memory-enhancing effect of β-lactolin. Methods and Results: The results of in vivo microdialysis revealed that oral administration of β-lactolin increased the extracellular concentration of dopamine in the hippocampus and enhanced both spatial working memory, as measured in the Y-maze test, and spatial reference memory, as measured in the novel object location test. These memory-enhancing effects of β-lactolin, but not the baseline memory functions, were impaired by the knockdown of the dopamine D1 receptor subtype in the hippocampus. β-Lactolin also enhanced object memory, as measured by the novel object recognition test. However, D1 knockdown in the hippocampus spared this memory function either with or without the administration of β-lactolin. Conclusions: The present results indicate that oral administration of β-lactolin increases dopamine release and D1 receptor signaling in the hippocampus, thereby enhancing spatial memory, but it may improve object memory via a separate mechanism.


Sign in / Sign up

Export Citation Format

Share Document